Retinal Changes in Parkinson's Disease: A Longitudinal Follow-up Study
Pooja Mailankody1, Rajani Battu2, Abhishek Lenka3
1Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.
Neurology India
|July 22, 2022
Summary
Longitudinal study reveals progressive retinal thinning in Parkinson's disease (PD) patients. This suggests non-dopaminergic pathway involvement, offering new insights into PD progression.
Area of Science:
- Ophthalmology
- Neurology
- Neuroscience
Background:
- Retinal involvement is evident in Parkinson's disease (PD).
- Previous studies lacked clarity on specific retinal changes due to cross-sectional designs.
Purpose of the Study:
- To investigate the longitudinal pattern of retinal layer changes in Parkinson's disease patients.
- To elucidate the progression of ocular manifestations in PD over time.
Main Methods:
- Spectral-domain Optical Coherence Tomography (SD-OCT) used for retinal imaging.
- 12 PD patients (23 eyes) underwent baseline and follow-up evaluations (mean 3.7 years).
- Assessment included visual acuity and Unified Parkinson's Disease Rating Scale (UPDRS) motor scores.
Main Results:
- Significant increase in Central Macular Thickness (CMT) observed (P = 0.002).
- Significant thinning of the outer temporal retinal layer noted (P = 0.001).
Conclusions:
- Serial retinal layer evaluation indicates progressive outer retinal thinning in PD.
- Non-dopaminergic mechanisms, particularly glutamatergic pathways, may drive these observed retinal changes.
Related Concept Videos
01:15Parkinson's Disease: Overview
690
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
690
01:24Parkinson's Disease: Treatment
366
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
366
02:20Longitudinal Research
12.3K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.3K